Amanta Healthcare IPO Date, Price, GMP, Review, Details

Investing in an IPO can sometimes feel like stepping into the unknown—exciting but a bit puzzling. Like setting out on a new adventure, knowing the map, important stops, and the weather forecast makes all the difference. When it comes to Amanta Healthcare IPO, understanding the date, price, Grey Market Premium (GMP), and detailed review is crucial for making confident investment decisions. This article will guide the general public through everything they need to know about Amanta Healthcare’s IPO with simple, clear language and easy steps.

Discover the Amanta Healthcare IPO date, price, GMP details, and how automated trading software can help investors. Stay updated on Amanta Healthcare IPO gmp.

What is Amanta Healthcare?

Amanta Healthcare is a pharmaceutical company specializing in manufacturing sterile liquid formulations such as intravenous (IV) fluids, eye drops, respiratory care solutions, and more. Founded in December 1994, the company operates out of a WHO-GMP compliant facility in Gujarat, India. It is known for using cutting-edge technologies like Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) in its production lines, ensuring quality and safety in its products.

The company also exports its products internationally and has over 45 generic formulations distributed through an extensive network. In many ways, Amanta Healthcare can be seen as a key player in the essential healthcare supply chain, especially in sterile liquid medicines.

Amanta Healthcare IPO Date

The IPO bidding window for Amanta Healthcare is set to open on September 1, 2025, and will close shortly on September 3, 2025. After this brief subscription window, the IPO allotment will be finalized around September 4, 2025, with refunds (if applicable) processed by September 8, 2025. Finally, shares are expected to be credited to investors’ Demat accounts, and the company’s shares should list on the BSE and NSE by September 9, 2025.

IPO Price Band and Lot Size

The price band for this IPO has been set between ₹120 and ₹126 per equity share with a face value of ₹10 each. The minimum lot size is 119 shares, which translates to a minimum investment of around ₹14,994 at the upper price band for retail investors.

For larger investors or Non-Institutional Investors (NII), the minimum application size is significantly bigger, requiring at least 14 lots for sub-NIIs and 67 lots for big NIIs, translating to investments in lakhs.

This pricing strategy ensures that the IPO is accessible to smaller retail investors while also inviting bigger players to contribute.

Grey Market Premium (GMP) Explained

The term Grey Market Premium (GMP) is like a weather forecast before a dawn—an informal but widely watched indicator of how the market expects the IPO to perform once it lists. GMP reflects the premium or discount at which shares are traded unofficially before listing on the stock exchange.

For Amanta Healthcare, the GMP has hovered around ₹22 to ₹23 per share, which suggests an expected listing price potentially around ₹148, indicating a prospective gain of nearly 17-18% over the IPO price band’s upper limit.

However, it’s crucial to remember that GMP is speculative and not guaranteed — it acts as a sentiment gauge rather than confirmed data

How to Apply for Amanta Healthcare IPO

Applying for the Amanta Healthcare IPO is straightforward:

Ensure a Demat account linked to a trading platform.

During the IPO subscription dates (Sep 1 to Sep 3, 2025), apply through your broker’s portal or the stock exchange’s online IPO subscription facility.

Specify the bid quantity and price within the stated band.

For retail investors, the minimum lot is 119 shares.

Payment is blocked temporarily and only debited if shares are allotted.

After allotment on September 4, shares will be credited by around September 8, followed by the public listing on September 9.

Company Financial Performance

Amanta Healthcare has shown promising financial trends:

Revenue (FY25) stood at approximately ₹274.71 crore, a slight dip from the previous year.

Profit After Tax (PAT) saw remarkable growth of nearly 189% year-over-year, reaching ₹10.50 crore.

EBITDA margins improved, reflecting stable operational efficiency.

Return on Equity (RoE) jumped to 12.42%, demonstrating better profitability for shareholders.

The debt-to-equity ratio improved, signaling stronger financial health.

This financial data suggests a well-managed company balancing cautious growth and profitability.

What Makes Amanta Healthcare IPO Attractive?

Several factors make this IPO appealing to investors:

Focus on sterile liquid pharmaceuticals, a niche but essential healthcare segment.

Use of advanced technology ensuring product quality.

Expanding domestic distribution and a foothold in international markets.

Robust financial performance showing profit growth with controlled debt.

Promising GMP indicating positive market sentiment.

Backed by reputed book runners and a transparent IPO process

Risks Associated with the IPO

Like any investment, risks exist:

Market volatility could affect the IPO listing price.

The pharma sector faces regulatory challenges and competition.

Slight recent revenue decline signals caution.

Investment is subject to the company’s ability to scale production and market reach successfully.

GMP is speculative, and actual listing gains may differ.

Understanding these risks helps investors make balanced decisions.

Role of Automated Trading Software in IPOs

Automated trading software acts like a GPS for investors in a bustling marketplace. It helps track IPO subscriptions, allotments, and live price movements with speed and accuracy, minimizing human error and emotional bias.

For Amanta Healthcare IPO, such software can ensure timely applications, optimize bidding within the price band, and alert about grey market movements or listing price shifts, making it especially useful for retail investors seeking an edge in the IPO process.

IPO Allotment and Listing Dates

Allotment finalization: September 4, 2025

Refund initiation (if applicable): September 8, 2025

Shares credited to Demat accounts: September 8, 2025

Listing on BSE and NSE: September 9, 2025

These dates represent the finishing line and the start of the public trading journey for Amanta Healthcare shares.

Expert Reviews and Market Sentiment

Industry experts highlight Amanta Healthcare’s strong fundamentals, technological edge, and healthy profit growth as positives. The healthy GMP hints at positive investor confidence, though caution is advised due to market volatility.

The IPO is seen as a good opportunity for retail investors looking at exposure to the healthcare manufacturing sector, especially given entry-level pricing and growth potential

Amanta Healthcare’s Future Outlook

With funds raised through this IPO, Amanta Healthcare plans to expand manufacturing lines at its Hariyala facility, further boosting capacity and product development. This expansion aligns with growth trends in sterile pharmaceutical demand worldwide, potentially raising long-term shareholder value.

Tips for First-Time IPO Investors

Research the company thoroughly.

Understand the IPO process and deadlines.

Consider risk tolerance and investment horizon.

Use automated trading tools for timely actions.

Avoid chasing hype; trust data and expert analysis.

Monitor GMP but do not solely rely on it.

Conclusion

The Amanta Healthcare IPO offers an intriguing opportunity for investors to partake in a niche healthcare segment with robust prospects. With clear subscription dates starting September 1, 2025, a well-set price band, and promising GMP signals, it combines excitement with calculated potential. Using automated trading software can further ease the journey, ensuring timely and organized participation. Like preparing for a trip with a dependable map and weather report, this IPO invites investors to act informed and confident.

FAQs on Amanta Healthcare IPO

Q1: When does the Amanta Healthcare IPO open and close?

The IPO opens on September 1, 2025, and closes on September 3, 2025.

Q2: What is the price band for this IPO?

The price band is set between ₹120 and ₹126 per share.

Q3: What is the Grey Market Premium (GMP) for Amanta Healthcare IPO?

Recently, GMP has hovered around ₹22-₹23, indicating a potential listing gain of about 17-18%.

Q4: How can I apply for the Amanta Healthcare IPO?

Investors can apply online through their Demat account or brokerage platform within the subscription dates.

Q5: What role does automated trading software play in IPO investments?

It helps investors apply promptly, manage bids efficiently, and stay updated on market movements related to the IPO.